ALS ONE is an unprecedented partnership of the top leaders, researchers, doctors and caretakers in ALS from Massachusetts General Hospital, UMass Medical School, Harvard Medical School, ALS Therapy Development Institute, and Compassionate Care ALS, who have joined forces to bring the strengths of their venerable institutions to an ambitious plan with one goal in mind:
A breakthrough treatment for ALS by 2020 and improved care now for those battling ALS.
Together, this team has identified the strongest therapeutic opportunities in ALS, and has developed a plan with the goal of bringing a treatment or cure to patients by 2020. Our approach is to leverage the expertise from the research institutions involved in a true partnership, including the sharing of ideas and responsibilities to advance each of the strongest opportunities identified forward.
The ALS ONE scientific plan is milestone driven, and will require significant funding to advance. The EAT TO DEFEAT ALS campaign can be a significant fundraiser and we hope you'll get involved. To learn more about ALS ONE, or to donate directly, please visitwww.ALSONE.org.
The ALS ONE Partnership Team with ALS ONE Founder, Kevin Gosnell, in 2015.